BackMetacrine Overview

Metacrine EBIT

EBIT (Earnings Before Interest and Taxes) analysis for MTCR.

Quarterly EBIT

-$5.16M
71.43% YoY

As of Sep 30, 2022

Annual EBIT (TTM)

-$36.51M
37.6% YoY

Trailing 12 months ending Sep 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)